Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19) Meeting Abstract


Authors: Aggarwal, R. R.; Dooley, K.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; Bryce, A. H.; Shevrin, D. H.; Mohler, J. L.; Anderson, D. M.; Heller, G.; Halabi, S.; Tan, A.; Eggener, S. E.; Ryan, C. J.; Morris, M. J.
Abstract Title: Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.5077
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 5077 -- This meeting was also held virtually -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Han Xiao
    59 Xiao
  3. Michael Morris
    577 Morris